IL6 and type 2 diabetes mellitus: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that unequivocally motivates IR progression and T2DM pathogenesis via inflammation generation by regulating differentiation, migration, proliferation, and apoptosis of cells [25].